SEQIRUS USA INC

Seqirus USA Inc. specializes in the manufacturing of biological products and pharmaceutical preparations, with a primary focus on influenza vaccines and other immunization therapies for government personnel. The company leverages advanced virology and biomanufacturing expertise to produce seasonal and pandemic-ready vaccine formulations under strict FDA and CDC guidelines, ensuring compliance with cGMP standards. Their technical capabilities include cell-based and egg-based vaccine production, lyophilization, cold chain logistics, and batch traceability systems critical for federal health security programs. Seqirus distinguishes itself through consistent delivery of high-volume, time-sensitive vaccine campaigns tailored to institutional needs, particularly for correctional, veteran, and federal workforce populations. The contractor maintains a deep, recurring relationship with the Department of Justice, supplying influenza vaccines for staff and inmate populations across federal correctional facilities. They also serve the Department of Veterans Affairs and the Department of Health and Human Services with seasonal immunization programs, demonstrating reliability in meeting public health mandates for high-risk and institutionalized groups. These partnerships reflect a pattern of sustained, mission-critical support for preventive health initiatives within federal custody and care systems. Seqirus USA Inc. operates primarily under NAICS 325412 (Pharmaceutical Preparation Manufacturing) and 325414 (Biological Product Manufacturing), focusing on injectable and multi-dose vaccine formulations for prophylactic use. Their market positioning centers on government biosecurity and public health preparedness, with specialization in flu vaccine supply chains and emergency response readiness. Headquartered in Summit, New Jersey, Seqirus USA Inc. is structured as a 2L entity with no active government certifications on record. The company maintains a focused footprint in the federal pharmaceutical supply market, delivering specialized biological products without reliance on third-party distribution channels.